Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q9NZJ6
UPID:
COQ3_HUMAN
Alternative names:
3-demethylubiquinol 3-O-methyltransferase; Polyprenyldihydroxybenzoate methyltransferase
Alternative UPACC:
Q9NZJ6; B3KPX0; Q5T061; Q6P4F0; Q8IXG6; Q96BG1; Q9H0N1
Background:
Ubiquinone biosynthesis O-methyltransferase, mitochondrial, also known as 3-demethylubiquinol 3-O-methyltransferase and Polyprenyldihydroxybenzoate methyltransferase, plays a crucial role in the ubiquinone biosynthetic pathway. This enzyme catalyzes the 2 O-methylation steps essential for the production of ubiquinone, a vital component in the mitochondrial electron transport chain.
Therapeutic significance:
Understanding the role of Ubiquinone biosynthesis O-methyltransferase could open doors to potential therapeutic strategies. Its pivotal function in energy production suggests that modulation of its activity could have implications for diseases related to mitochondrial dysfunction.